Literature DB >> 17766243

Menin-mediated caspase 8 expression in suppressing multiple endocrine neoplasia type 1.

Ping La1, Yuqing Yang, Satyajit K Karnik, Albert C Silva, Robert W Schnepp, Seung K Kim, Xianxin Hua.   

Abstract

Multiple endocrine neoplasia type 1 (MEN1) is a familial tumor syndrome linked to mutation of the MEN1 gene, which encodes a tumor suppressor, menin. We previously reported that menin up-regulates the caspase 8 expression and promotes TNF-alpha-induced apoptosis. However, it remains unclear how menin up-regulates caspase 8 expression and whether menin-mediated caspase 8 expression plays a role in repressing MEN1 development. Here we show that menin binds the 5'-untranslated region (5'-UTR) of the Caspase 8 locus in vivo and activates transcription of a reporter gene through the 5'-UTR. Menin directly binds the 5'-UTR in a sequence-independent manner in vitro. Moreover, Men1 ablation in cells reduces acetylation of histones H3 and H4 at the 5'-UTR of the caspase 8 locus bound by menin in vivo. Notably, the MEN1-derived menin point mutants lose their ability to bind the caspase 8 locus and fail to induce caspase 8 expression and TNF-alpha-mediated apoptosis. Consistent with these observations, the expression level of caspase 8 is markedly reduced in insulinomas from Men1(+/-) mice. Together, our results indicate that menin enhances the caspase 8 expression by binding the caspase 8 locus, and suggest that menin suppresses MEN1 tumorigenesis, at least in part, by up-regulating caspase 8 expression.

Entities:  

Mesh:

Substances:

Year:  2007        PMID: 17766243      PMCID: PMC2858561          DOI: 10.1074/jbc.M609555200

Source DB:  PubMed          Journal:  J Biol Chem        ISSN: 0021-9258            Impact factor:   5.157


  51 in total

Review 1.  The diverse functions of histone acetyltransferase complexes.

Authors:  Michael J Carrozza; Rhea T Utley; Jerry L Workman; Jacques Côté
Journal:  Trends Genet       Date:  2003-06       Impact factor: 11.639

2.  Complexes containing the retinoblastoma gene product recognize different DNA motifs related to the E2F binding site.

Authors:  M M Ouellette; J Chen; W E Wright; J W Shay
Journal:  Oncogene       Date:  1992-06       Impact factor: 9.867

3.  A mouse model of multiple endocrine neoplasia, type 1, develops multiple endocrine tumors.

Authors:  J S Crabtree; P C Scacheri; J M Ward; L Garrett-Beal; M R Emmert-Buck; K A Edgemon; D Lorang; S K Libutti; S C Chandrasekharappa; S J Marx; A M Spiegel; F S Collins
Journal:  Proc Natl Acad Sci U S A       Date:  2001-01-30       Impact factor: 11.205

4.  Caspase 8 is deleted or silenced preferentially in childhood neuroblastomas with amplification of MYCN.

Authors:  T Teitz; T Wei; M B Valentine; E F Vanin; J Grenet; V A Valentine; F G Behm; A T Look; J M Lahti; V J Kidd
Journal:  Nat Med       Date:  2000-05       Impact factor: 53.440

5.  Silencing of death receptor and caspase-8 expression in small cell lung carcinoma cell lines and tumors by DNA methylation.

Authors:  S Hopkins-Donaldson; A Ziegler; S Kurtz; C Bigosch; D Kandioler; C Ludwig; U Zangemeister-Wittke; R Stahel
Journal:  Cell Death Differ       Date:  2003-03       Impact factor: 15.828

6.  Menin localizes to chromatin through an ATR-CHK1 mediated pathway after UV-induced DNA damage.

Authors:  Steven M Farley; Gao Chen; Sydney Guo; Min Wang; Jingbo A; Felix Lee; Frank Lee; Mark Sawicki
Journal:  J Surg Res       Date:  2006-06-01       Impact factor: 2.192

7.  The menin tumor suppressor protein is an essential oncogenic cofactor for MLL-associated leukemogenesis.

Authors:  Akihiko Yokoyama; Tim C P Somervaille; Kevin S Smith; Orit Rozenblatt-Rosen; Matthew Meyerson; Michael L Cleary
Journal:  Cell       Date:  2005-10-21       Impact factor: 41.582

8.  Genetic ablation of the tumor suppressor menin causes lethality at mid-gestation with defects in multiple organs.

Authors:  Philippe Bertolino; Ivan Radovanovic; Huguette Casse; Adriano Aguzzi; Zhao-Qi Wang; Chang-Xian Zhang
Journal:  Mech Dev       Date:  2003-05       Impact factor: 1.882

9.  Pancreatic beta-cell-specific ablation of the multiple endocrine neoplasia type 1 (MEN1) gene causes full penetrance of insulinoma development in mice.

Authors:  Philippe Bertolino; Wei-Min Tong; Pedro Luis Herrera; Huguette Casse; Chang Xian Zhang; Zhao-Qi Wang
Journal:  Cancer Res       Date:  2003-08-15       Impact factor: 12.701

10.  Tumor suppressor menin regulates expression of insulin-like growth factor binding protein 2.

Authors:  Ping La; Robert W Schnepp; Clark D Petersen; Albert C Silva; Xianxin Hua
Journal:  Endocrinology       Date:  2004-03-24       Impact factor: 4.736

View more
  13 in total

1.  Menin represses tumorigenesis via repressing cell proliferation.

Authors:  Ting Wu; Xianxin Hua
Journal:  Am J Cancer Res       Date:  2011-05-16       Impact factor: 6.166

2.  Expression and subcellular localization of menin in human cancer cells.

Authors:  Feng Ren; Hong-Wei Xu; Yu Hu; Shuang-Hong Yan; Feng Wang; Bao-Wei Su; Qi Zhao
Journal:  Exp Ther Med       Date:  2012-03-29       Impact factor: 2.447

3.  Regulation of cyclin B2 expression and cell cycle G2/m transition by menin.

Authors:  Ting Wu; Xiuli Zhang; Xiaohua Huang; Yuqing Yang; Xianxin Hua
Journal:  J Biol Chem       Date:  2010-04-19       Impact factor: 5.157

4.  Proliferation rates of multiple endocrine neoplasia type 1 (MEN1)-associated tumors.

Authors:  Gerard V Walls; Anita A C Reed; Jeshmi Jeyabalan; Mahsa Javid; Nathan R Hill; Brian Harding; Rajesh V Thakker
Journal:  Endocrinology       Date:  2012-09-28       Impact factor: 4.736

5.  A simple matter of life and death-the trials of postnatal Beta-cell mass regulation.

Authors:  Elena Tarabra; Stella Pelengaris; Michael Khan
Journal:  Int J Endocrinol       Date:  2012-04-22       Impact factor: 3.257

6.  Loss of MEN1 activates DNMT1 implicating DNA hypermethylation as a driver of MEN1 tumorigenesis.

Authors:  Ziqiang Yuan; Carmen Sánchez Claros; Masako Suzuki; Elaine C Maggi; Justin D Kaner; Noah Kinstlinger; Jolanta Gorecka; Thomas J Quinn; Rula Geha; Amanda Corn; Jessica Pastoriza; Qiang Jing; Asha Adem; Hao Wu; Girum Alemu; Yi-Chieh Du; Deyou Zheng; John M Greally; Steven K Libutti
Journal:  Oncotarget       Date:  2016-03-15

7.  Menin mediates Tat-induced neuronal apoptosis in brain frontal cortex of SIV-infected macaques and in Tat-treated cells.

Authors:  Jun Wang; Yu Zhang; Qiping Xu; Jinhua Qiu; Honghua Zheng; Xiang Ye; Yuhua Xue; Yongmei Yin; Zhou Zhang; Ying Liu; Yanling Hao; Qiang Wei; Wei Wang; Kazuyasu Mori; Shuji Izumo; Ryuji Kubota; Yiming Shao; Hui Qin Xing
Journal:  Oncotarget       Date:  2017-03-14

8.  MEN1 gene replacement therapy reduces proliferation rates in a mouse model of pituitary adenomas.

Authors:  Gerard V Walls; Manuel C Lemos; Mahsa Javid; Miriam Bazan-Peregrino; Jeshmi Jeyabalan; Anita A C Reed; Brian Harding; Damian J Tyler; Daniel J Stuckey; Sian Piret; Paul T Christie; Olaf Ansorge; Kieran Clarke; Len Seymour; Rajesh V Thakker
Journal:  Cancer Res       Date:  2012-08-21       Impact factor: 12.701

Review 9.  Current and emerging therapies for PNETs in patients with or without MEN1.

Authors:  Morten Frost; Kate E Lines; Rajesh V Thakker
Journal:  Nat Rev Endocrinol       Date:  2018-02-16       Impact factor: 43.330

Review 10.  Multiple endocrine neoplasia type 1 (MEN1) and type 4 (MEN4).

Authors:  Rajesh V Thakker
Journal:  Mol Cell Endocrinol       Date:  2013-08-08       Impact factor: 4.102

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.